MARATTO

article · Malawi Medical Journal

Characterization of Mycobacterium Tuberculosis (MTB)-Positive Individuals within the Healthcare Catchment Area of Mzuzu Central Hospital, Malawi

2025Open accessMzuzu University

Abstract

Purpose: To investigate the characteristics of the Mycobacterium tuberculosis (MTB)-positive population within the healthcare service area of Mzuzu Central Hospital in Malawi, with the objective of providing a scientific foundation for tuberculosis (TB) prevention and control strategies in the region. Methods: This retrospective study encompassed 4,711 patients who underwent GeneXpert (GeneXpert MTB/RIF or GeneXpert MTB/RIF Ultra) testing. Data on laboratory results, demographics, HIV status, and residential addresses were analyzed. Results: =66.858, p<0.001) than that for females, which stands at 5.6% (133/2370), irrespective of HIV status. The age distribution of MTB-positive patients peaked in the 21-55 age bracket, with a median age of 37.0 (29.0, 47.0). The third quarter of each year, particularly September exhibited the highest positivity rate of 13.1%. Within Mzimba District, 87.8% of TB patients resided in Mzuzu city, with Luwinga (21.8%), Mchengautuwa (12.5%), and Zolozolo (9.9%) being the top three townships. Most newly diagnosed cases received treatment (85.1%), but the rifampicin resistance rate (4.7%) exceeded the national average. Conclusion: Within the healthcare catchment area of Mzuzu Central Hospital, MTB infection is significantly associated with HIV. Males show a higher MTB positivity rate than females. The study identifies high-risk age groups, temporal trends, and geographical TB patterns. Rifampicin resistance is a critical issue needing urgent attention.

Research topics

  • Tuberculosis Research and Epidemiology
  • Diagnosis and treatment of tuberculosis
  • Healthcare Facilities Design and Sustainability

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4314/mmj.v37i1.2

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.